Among the genus Rothia, Rothia dentocariosa and Rothia mucilaginosa are found in oral cavity and pharynx of humans. Furthermore, there is only one report that Rothia aeria, which is capable of causing serious systemic infections, has been also detected in the mouths of healthy individuals. A suitable selective medium for the isolation of R. aeria is necessary to assess the veritable prevalence of this organism in the oral cavity. To examine the bacterium population in the oral cavity, a novel selective medium, designated RASM, was developed for the isolation of R. aeria. RASM consists of sodium gluconate, tryptone, lablemco powder and aztreonam. Average growth recovery of R. aeria on RASM was 96.1％ compared with that on BHI-Y agar. Growth of other representative oral bacteria including R. dentocariosa, R. mucilaginosa, genera Actinomyces, Neisseria, and Corynebacterium were remarkably inhibited on the selective medium. Though the inhibitions of certain strains of streptococci were not complete, they formed small or pin colony on RASM and could be distinguished from R. aeria colony. Clinical efficacy was evaluated by the recovery of R. aeria on RASM from the stimulated saliva samples of ten volunteers. R. aeria was detected at 3.1（range: 0.5-14.4)％ to total bacteria of 7.0×10 7 CFU/ml on BHI-Y agar in their oral cavities. The new selective medium, RASM, was useful for the isolation of R. aeria. Moreover, we examined the antibiotic susceptibility of twenty isolates from four subjects. The bacterium was susceptible to most antibiotics; however R. aeria isolates from one subject were highly resistant to erythromycin, lincomycin, and clindamycin.
Introduction
There are actually six species in genus Rothia：Rothia aeria, Rothia amarae, Rothia dentocariosa, Rothia mucilaginosa, Rothia nasimurium, and Rothia terrae(1-5） . Among the six Rothia species, R. dentocariosa and R. mucilaginosa are found in the oral cavity and pharynx of humans(6-10） .
Concerning R. aeria, it was first isolated from air and condensation water samples from the Russian space station, Mir (1） . R. aeria is capable of causing serious systemic infections, such as sepsis, bronchitis, pneumonia, and endocarditis(13-17） . There is only one report that R. aeria has been also detected in the mouths of healthy individuals (18） . We previously reported each selective medium for the isolation of R. dentocariosa and R. mucilaginosa(8, 9） . Since both selective media inhibit the growth of R. aeria, and this organism has never been detected in our previous studies, we did not know whether R. aeria is normal oral flora or not.
Therefore, a suitable selective medium for the isolation of R. aeria is necessary to assess the veritable prevalence of this organism in the oral cavity. According to some previously described case reports on serious systemic infections, R. aeria isolates from clinical specimens such as blood is susceptible to many antibiotics (14-16） ；however, it demonstrates only intermediate susceptibility to clindamycin and vancomycin(14） .
Resistance to clindamycin(16） , aztreonam(16）and ofloxacin(15）determined using disk diffusion tests has also been reported.
The purpose of this study was to develop a new selective medium for the isolation of R. aeria and to investigate its distribution in the oral cavity. Moreover, in order to expand the knowledge of R. aeria, we examined the antibiotic susceptibility of the isolates from the oral cavities.
Material and Methods

Bacterial strains and culture conditions
All bacterial strains used in this study are listed in Table   1 
Identification of R. aeria from clinical samples
Ten colonies per subject on the selective medium were subcultured to confirm by polymerase chain reaction（PCR） analysis.
PCR analysis
PCR analysis for the identification of R. aeria was 
Antibiotics susceptibility tests of R. aeria isolates
Antibiotics susceptibilities of R. aeria isolates were characterized using microdilution method. Antibiotics used in this study are listed in Table 4 . They are widely used in the treatment of Gram-positive bacterial infections.
Although no Clinical and Laboratory Standards Institute （CLSI）protocols exist for R. aeria, we assessed the organismʼs drug susceptibility utilizing the 2009 CLSI criteria（M100-S19）for staphylococci.
Results
Evaluation of the base medium
A base medium for the growth of R. aeria has been studied. R. aeria grew well on BHI-Y agar and the test medium, which was a little modified RSM (19） , at similar ratios（data not shown） . Oral streptococci（Streptococcus oralis, Streptococcus salivarius, and Streptococcus anginosus）and oral rothia（R. dentocariosa and R. mucilaginosa） formed small or pin colonies on the test medium, and genera Actinomyces, Neisseria, and Corynebacterium did not grow on it（data not shown） . Finally, a base medium was determined the test medium, because it inhibited the growth of other bacteria and the colony size of R. aeria on the test medium was similar to that on BHI-Y agar.
Susceptibility to antibiotics R. aeria was resistant to aztreonam. The minimal inhibitory concentration（MIC）of aztreonam to R. aeria, R. dentocariosa, and R. mucilaginosa was 250 μg/ml, 100 μg/ml, and 50 μg/ml, respectively.
Composition of new selective medium
The new selective medium, designated R. aeria selective the agar medium such that they were not easily scraped off.
The size of colonies on RASM ranged 1.3 to 2.1 mm in diameter after 72 h incubation. Table 2 
Clinical examination
The proportion of R. aeria in saliva from ten subjects on BHI-Y agar and RASM is shown in Table 3 . The mean number of total bacteria was 0. Antibiotics susceptibility tests of R. aeria isolates Table 4 shows the antibiotics susceptibility tests of R. aeria isolates. Reference strains and clinical isolates of R. aeria were susceptible to most antibacterial agents.
Among the subjects, the isolates from subject B were highly resistant to erythromycin, lincomycin and clindamycin.
Discussion
R. dentocariosa and R. mucilaginosa are part of the normal flora in the human oral cavity and pharynx(6-10） .
R. aeria was first isolated from air and condensation water samples from the Russian space station, Mir (1） . R. aeria was originally classified as R. dentocariosa genomovar II before the report of Li et al.(1） . We were unable to find any To examine the bacterium population in the oral cavity, a novel selective medium, designated RASM, was developed for the isolation of R. aeria in this study. RASM was highly selective for R. aeria.
On medical clinical microbiological examination, Rothia species can be mistaken for bacteria such as Dermabacter hominis, Actinomyces viscosus, Propionibacterium avidum, Corynebacterium matruchotii and Nocardia species, because many laboratories are unfamiliar with these organisms, which may be difficult to culture due to same Gram positive Fig. 1 Appearance of R. aeria colonies on RASM Ａ：R. aeria colonies on RASM inoculated with saliva sample Ｂ：Stereomicroscope image of R. aeria colony on RASM Table 2 Growth of other representative oral bacteria on BHI-Y and RASM In this study, R. aeria was detected from all subjects, and accounted for 3.1％ of total bacteria in saliva. In our previous studies, R. dentocariosa and R. mucilaginosa accounted for 2.6％ and 3.4％ of total bacteria in saliva respectively(8, 9） . These results indicated that R. aeria is part of normal flora in the oral cavity as same as known oral rotiha, R. dentocariosa and R. mucilaginosa.
In this study, R. aeria was susceptible to most antibiotics, however clinical isolates of R. aeria from one subject were highly resistant to erythromycin, lincomycin, and clindamycin. Clinical isolates of R. aeria in this study were more highly resistant to some antibiotics than the strains of some previously described case reports on serious systemic infections. It might be necessary to monitor the antibiotics resistance of R. aeria continually.
We developed a novel selective medium with high selectivity, designated RASM, for the isolation of R. aeria.
RMSM is useful for determining the distribution and role of this organism in oral cavities.
